The company expired its plan on March 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 CNY | +0.20% | -2.76% | -22.81% |
20/05 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
08/05 | US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A | MT |
1st Jan change | Capi. | |
---|---|---|
-22.81% | 42Cr | |
+16.31% | 4.23TCr | |
+16.32% | 2.13TCr | |
+19.36% | 1.53TCr | |
+18.71% | 1.44TCr | |
+52.78% | 1.28TCr | |
-0.05% | 678.76Cr | |
-12.24% | 658.31Cr | |
-8.87% | 572.55Cr | |
+11.64% | 550.82Cr |
- Stock Market
- Equities
- 002082 Stock
- News Wanbangde Pharmaceutical Holding Group Co., Ltd.
- Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback announced on March 15, 2021, has expired with 5,000,000 shares, representing 0.81% for CNY 59.98 million.